Setting

Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248426 | Pages: 140

Europe pharmaceutical contract research organization (CRO) market was valued at $12.13 billion in 2021 and will grow by 9.6% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 69 tables and 48 figures, this 140-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country. Based on Service, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • CRO for Pre-clinical Development • CRO for Phase I Trials • CRO for Phase II Trials • CRO for Phase III Trials • CRO for Phase IV Trials • Laboratory Services • Consulting Services • Data Management Services Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • Infectious Diseases • Oncology • Metabolic Disorders • Cardiovascular Disorders • Central Nervous System • Respiratory Disorders • Gastrointestinal Disorders • Other Therapeutic Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • Pharmaceutical & Biopharmaceutical Companies • Medical Device Companies • Academic Institutes Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories CMIC Co. Ltd Covance Inc. Hangzhou Tigermed Consulting Co., Ltd. ICON Plc IQVIA Holdings Inc. LSK Europe Pharma Service Co., Ltd. Novotech Pty Ltd PAREXEL International Corporation Pharmaceutical Product Development LLC (PPD) PRA Health Sciences Inc. Quanticate Ltd Samsung Bioepis Co., Ltd. SGS SA (SGS Life Sciences) Syneos Health Inc. WuXi AppTec Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	33
2.4 Emerging Opportunities and Market Trends	36
2.5 Porter’s Fiver Forces Analysis	40
3 Segmentation of Europe Market by Service	44
3.1 Market Overview by Service	44
3.2 CRO for Pre-clinical Development	46
3.3 CRO for Phase I Trials	47
3.4 CRO for Phase II Trials	48
3.5 CRO for Phase III Trials	49
3.6 CRO for Phase IV Trials	50
3.7 Laboratory Services	51
3.8 Consulting Services	52
3.9 Data Management Services	53
4 Segmentation of Europe Market by Therapeutic Application	54
4.1 Market Overview by Therapeutic Application	54
4.2 Infectious Diseases	56
4.3 Oncology	57
4.4 Metabolic Disorders	58
4.5 Cardiovascular Disorders	59
4.6 Central Nervous System	60
4.7 Respiratory Disorders	61
4.8 Gastrointestinal Disorders	62
4.9 Other Therapeutic Applications	63
5 Segmentation of Europe Market by End User	64
5.1 Market Overview by End User	64
5.2 Pharmaceutical & Biopharmaceutical Companies	66
5.3 Medical Device Companies	67
5.4 Academic Institutes	68
6 European Market 2019-2030 by Country	69
6.1 Overview of European Market	69
6.2 Germany	72
6.3 UK	74
6.4 France	77
6.5 Spain	79
6.6 Italy	81
6.7 Russia	83
6.8 Rest of European Market	85
7 Competitive Landscape	87
7.1 Overview of Key Vendors	87
7.2 New Product Launch, Partnership, Investment, and M&A	91
7.3 Company Profiles	92
Charles River Laboratories	92
CMIC Co. Ltd	94
Covance Inc.	96
Hangzhou Tigermed Consulting Co., Ltd.	100
ICON Plc	103
IQVIA Holdings Inc.	106
LSK Global Pharma Service Co., Ltd.	110
Novotech Pty Ltd	112
PAREXEL International Corporation	114
Pharmaceutical Product Development LLC (PPD)	118
PRA Health Sciences Inc.	120
Quanticate Ltd	122
Samsung Bioepis Co., Ltd.	124
SGS SA (SGS Life Sciences)	126
Syneos Health Inc.	129
WuXi AppTec Inc.	132
8 Investing in Europe Market: Risk Assessment and Management	134
8.1 Risk Evaluation of Europe Market	134
8.2 Critical Success Factors (CSFs)	137
Related Reports and Products	140
List Of Tables:


Table 1.  Snapshot of Europe Pharmaceutical CRO Market in Balanced Perspective, 2019-2030	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn	27
Table 4. Worldwide Total Number of Registered Clinical Trials	29
Table 5. World Health Spending by Region, $ bn, 2013-2020	32
Table 6.  Main Product Trends and Market Opportunities in Europe Pharmaceutical CRO Market	36
Table 7. Europe Pharmaceutical CRO Market by Service, 2019-2030, $ bn	44
Table 8. Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	54
Table 9. Europe Pharmaceutical CRO Market by End User, 2019-2030, $ bn	64
Table 10. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn	71
Table 11. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn	73
Table 12. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	73
Table 13. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn	73
Table 14. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn	76
Table 15. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	76
Table 16. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn	76
Table 17. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn	78
Table 18. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	78
Table 19. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn	78
Table 20. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn	80
Table 21. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	80
Table 22. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn	80
Table 23. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn	82
Table 24. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	82
Table 25. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn	82
Table 26. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn	84
Table 27. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	84
Table 28. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn	84
Table 29. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn	86
Table 30. Breakdown of World Market by Key Vendor, 2020, %	89
Table 31. Charles River Laboratories: Company Snapshot	92
Table 32. Charles River Laboratories: Product Portfolio	93
Table 33. CMIC Co. Ltd.: Company Snapshot	94
Table 34. CMIC Co. Ltd.: Business Segmentation	95
Table 35. CMIC Co. Ltd.: Revenue by Region, 2018, %	95
Table 36. Covance Inc.: Company Snapshot	96
Table 37. Covance Inc.: Product Portfolio	97
Table 38. Covance Inc.: Revenue by Region, 2020, %	98
Table 39. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot	100
Table 40. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation	101
Table 41. ICON Plc: Company Snapshot	103
Table 42. ICON Plc: Business Segmentation	103
Table 43. ICON Plc: Product Portfolio	104
Table 44. ICON Plc: Revenue by Region, 2020, %	104
Table 45. IQVIA Holdings Inc.: Company Snapshot	106
Table 46. IQVIA Holdings Inc.: Business Segmentation	107
Table 47. IQVIA Holdings Inc.: Revenue by Region, 2020, %	107
Table 48. IQVIA Holdings Inc.: Product Portfolio	108
Table 49. LSK Global Pharma Service Co., Ltd.: Company Snapshot	110
Table 50. Novotech Pty Ltd: Company Snapshot	112
Table 51. PAREXEL International Corporation: Company Snapshot	114
Table 52. PAREXEL International Corporation: Business Segmentation	115
Table 53. PAREXEL International Corporation: Revenue by Region, 2018, %	115
Table 54. PAREXEL International Corporation: Product Portfolio	116
Table 55. Pharmaceutical Product Development LLC (PPD): Company Snapshot	118
Table 56. PRA Health Sciences Inc.: Company Snapshot	120
Table 57. PRA Health Sciences Inc.: Business Segmentation	121
Table 58. PRA Health Sciences Inc.: Revenue by Region, 2018, %	121
Table 59. Quanticate Ltd: Company Snapshot	122
Table 60. Samsung Bioepis Co., Ltd.: Company Snapshot	124
Table 61. SGS SA (SGS Life Sciences): Company Snapshot	126
Table 62. SGS SA (SGS Life Sciences): Business Segmentation	127
Table 63. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %	127
Table 64. Syneos Health Inc.: Company Snapshot	129
Table 65. Syneos Health Inc.: Business Segmentation	130
Table 66. Syneos Health Inc.: Revenue by Region, 2018, %	130
Table 67. WuXi AppTec Inc.: Company Snapshot	132
Table 68.  Risk Evaluation for Investing in Europe Market, 2021-2030	135
Table 69. Critical Success Factors and Key Takeaways	138
List Of Figures:


Figure 1.  Research Method Flow Chart	11
Figure 2. Breakdown of Primary Research	13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030	17
Figure 5. Europe Pharmaceutical CRO Market, 2019-2030, $ bn	20
Figure 6. Impact of COVID-19 on Business	23
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical CRO Market	25
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	30
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	31
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	31
Figure 11. Primary Restraints and Impact Factors of Europe Pharmaceutical CRO Market	33
Figure 12. Investment Opportunity Analysis	37
Figure 13. Porter’s Fiver Forces Analysis of Europe Pharmaceutical CRO Market	40
Figure 14. Breakdown of Europe Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue	45
Figure 15. Europe Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%)	45
Figure 16. Europe Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn	46
Figure 17. Europe Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn	47
Figure 18. Europe Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn	48
Figure 19. Europe Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn	49
Figure 20. Europe Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn	50
Figure 21. Europe Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn	51
Figure 22. Europe Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn	52
Figure 23. Europe Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn	53
Figure 24. Breakdown of Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue	55
Figure 25. Europe Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%)	55
Figure 26. Europe Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn	56
Figure 27. Europe Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn	57
Figure 28. Europe Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn	58
Figure 29. Europe Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn	59
Figure 30. Europe Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn	60
Figure 31. Europe Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn	61
Figure 32. Europe Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn	62
Figure 33. Europe Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn	63
Figure 34. Breakdown of Europe Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue	65
Figure 35. Europe Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%)	65
Figure 36. Europe Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn	66
Figure 37. Europe Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn	67
Figure 38. Europe Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn	68
Figure 39. Breakdown of European Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue	70
Figure 40. Contribution to Europe 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	71
Figure 41.  Pharmaceutical CRO Market in Germany, 2019-2030, $ bn	72
Figure 42.  Pharmaceutical CRO Market in UK, 2019-2030, $ bn	74
Figure 43.  Pharmaceutical CRO Market in France, 2019-2030, $ bn	77
Figure 44.  Pharmaceutical CRO Market in Spain, 2019-2030, $ bn	79
Figure 45.  Pharmaceutical CRO Market in Italy, 2019-2030, $ bn	81
Figure 46.  Pharmaceutical CRO Market in Russia, 2019-2030, $ bn	83
Figure 47.  Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn	85
Figure 48. Growth Stage of Europe Pharmaceutical CRO Industry over the Forecast Period	87
Selected Key Players: 
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)